Theoretical–Cheminformatic Study of Four Indolylphytoquinones, Prospective Anticancer Candidates
<b>Background/Objectives:</b> Breast cancer is a disease with a high mortality rate worldwide; consequently, urgent achievements are required to design new greener drugs, leaving natural products and their derivatives as good options. A constant antineoplastic effect has been observed when the phytoproduct contains an indole fragment. <b>Methods:</b> Therefore, the objective of this work was to carry out a thoughtful computational study to perform an appropriate evaluation of four novel molecules of the class of the 3-indolylquinones as phytodrug candidates for antineoplastic activity: thymoquinone (TQ), 2,6-dimethoxy-1,4-benzoquinone (DMQ), 2,3-dimethoxy-5-methyl-1,4-benzoquinone (DMMQ), and 2,5-dihydroxy-1,4-benzoquinone (DHQ). It is important to highlight that the obtained computational results of the target compounds were compared-correlated with the theoretical and experimental literature data previously reported of several indolylquinones: indolylperezone, indolylisoperezone, indolylmenadione, and indolylplumbagin (IE-IH, respectively). Results: The results revealed that the studied structures possibly presented antineoplastic activity, in addition to the fact that the reactivity parameters showed that two of the evaluated compounds have the option to present IC<sub>50</sub> values lower than or similar to 25 mg/mL, activity like that of indolylisoperezone; moreover, they show molecular coupling to PARP-1. Finally, the prediction of the calculated physicochemical parameters coincides with the Lipinski and Veber rules, indicating that the adsorption, metabolism, and toxicity parameters are acceptable for the studied compounds, obtaining high drug score values. <b>Conclusions:</b> Finally, a comparison between the proposed molecules and others previously synthesized was appropriately performed, establishing that the synthesis of the studied compounds and the determination of their pharmacological properties in an experimental manner are of interest.
Authors
- René Miranda (ORCID: https://orcid.org/0000-0002-1979-5590)
- Edgar Daniel Moyers-Montoya (ORCID: https://orcid.org/0000-0001-6293-1941)
- Carlos A. Perez (ORCID: https://orcid.org/0000-0002-1136-6812)
- María Inés Nicolás‐Vázquez (ORCID: https://orcid.org/0000-0003-0722-5045)
- Perla E. García‐Casillas (ORCID: https://orcid.org/0000-0003-2139-1154)
- René Gerardo Escobedo-González (ORCID: https://orcid.org/0000-0002-0640-0705)
- Wilber Montejo-López (ORCID: https://orcid.org/0000-0001-6031-3410)
- María Jazmín Castañeda-Muñoz
- Daniel Márquez-Olivas
Institutions
- Universidad Autónoma de Ciudad Juárez (MX)
- Universidad Autónoma de Coahuila (MX)
- Universidad de Cuautitlán Izcalli (MX)
- Hospital de Especialidades (MX)
- Universidad Autónoma de Chiapas (MX)
- Instituto Tecnológico de Ciudad Juárez (MX)
- Universidad Tecnologica de Ciudad Juarez
- Universidad Nacional Autónoma de México (MX)
- Tecnológico de Monterrey (MX)
Publication Details
- Journal
- Pharmaceuticals
- Published
- 2024-11-26
- DOI
- https://doi.org/10.3390/ph17121595
- Citations
- 1
- Primary Topic
- Bioactive Compounds and Antitumor Agents
- Type
- article
- Field-Weighted Citation Impact
- 0.35
Funders
- Dirección General de Asuntos del Personal Académico, Universidad Nacional Autónoma de México